利用相互连接的未折叠蛋白质反应和NLRP3炎症酶途径,在扩散的大B细胞淋巴瘤中重新激活爱斯坦-巴尔病毒
Huanzhou Xu1, Tarun E Hutchinson2, Siva Koganti1
1Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, FL 32610, United States.
NAR cancer
|May 7, 2025
概括
在扩散性大B细胞淋巴瘤 (DLBCL) 中,爱斯坦-巴尔病毒 (EBV) 的重新激活是复杂的. 展开的蛋白质反应和炎症酶途径控制了EBV的溶解周期,提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 在免疫功能低下的患者中,扩散性大B细胞淋巴瘤 (DLBCL) 与爱斯坦-巴尔病毒 (EBV) 存在治疗挑战.
- 性诱导疗法旨在重新激活潜伏的EBV,以直接杀死瘤细胞并使其对抗病毒药物敏感.
研究的目的:
- 研究EBV阳性DLBCL细胞系中的EBV再激活机制.
- 探索展开的蛋白质反应 (UPR) 和炎症体在EBV重新激活中的作用.
- 为了评估结合的Lytic诱导和甘西克洛维尔治疗的疗效.
主要方法:
- 对四种EBV阳性DLBCL细胞系对溶液刺激的反应进行分析.
- 研究未折叠蛋白质响应 (UPR) 途径,包括XBP1,TXNIP和NLRP3.
- 评估炎酶激活及其对EBV BZLF1转录的影响.
- 对结合的Lytic诱导和甘西克洛维尔治疗对细胞死亡的评估.
主要成果:
- 在DLBCL细胞系中EBV的重新激活显示出可变的,往往是流产的,没有病毒释放的反应.
- 通过XBP1,UPR可以对TXNIP和NLRP3进行上调,从而激活炎症酶.
- 炎症酶激活促进了EBV潜向-lytic切换基因BZLF1的转录.
- 催化剂诱导和甘西克洛维尔的联合疗法增强了性细胞死亡.
结论:
- 在控制DLBCL中的EBV重新激活方面,UPR和炎症酶途径之间存在联系.
- 针对这些途径可以成为DLBCL新型EBV向治疗的基础.
- 控制的EBV溶性活性可能会改善EBV阳性DLBCL患者的治疗结果.
相关概念视频
Regulation of the Unfolded Protein Response
2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K
The Intrinsic Apoptotic Pathway
5.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K
The Unfolded Protein Response
4.3K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.3K
B Cell Activation and Differentiation
1.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.2K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Immune Response Against Viral Pathogens
478
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
478


